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Abstract
Activated T cells must mediate effector responses sufficient to clear pathogens while avoiding 
excessive tissue damage. Here we have combined dynamic intravital microscopy with ex vivo 
assessments of T cell cytokine responses to generate a detailed spatiotemporal picture of CD4+ T 
cell effector regulation in the skin. In response to antigen, effector T cells arrested transiently on 
antigen presenting cells, briefly producing cytokine and then resuming migration. Antigen 
recognition led to PD-1 upregulation of the programmed death-1 (PD-1) glycoprotein by T cells 
and blocking its canonical ligand, programmed death-ligand 1 (PD-L1), lengthened the duration of 
migration arrest and cytokine production, showing that PD-1 interaction with PD-L1 is a major 
negative feedback regulator of antigen responsiveness. We speculate that the immune system 
employs a mechanism involving T cell recruitment, transient activation, and rapid desensitization, 
allowing the T cell response to rapidly adjust to changes in antigen presentation and minimize 
collateral injury to the host.
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Introduction
Effector T cells develop from naïve T cell precursors in secondary lymphoid organs upon 
encountering processed antigen (pMHC ligands) on antigen-presenting cells (APCs). 
Following activation, clonal expansion, and differentiation, the T cells acquire the capacity 
to produce distinct sets of effector cytokines and through the expression of specific tissue 
homing receptors, to access sites of infection or cellular damage via locally inflamed 
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endothelium (Campbell and Butcher, 2002; Mora et al., 2003) where they play a crucial role 
in control of microbial infections and tumors and are major contributors to tissue-specific 
autoimmunity (Swain et al., 2012; Zhu et al., 2010).
Once effector T cells enter into inflamed tissue and recognize their specific antigen on tissue 
resident APCs, they undergo reactivation, producing effector cytokines that can contribute to 
host defense by enhancing anti-microbial responses. Local chemokine production by these 
activated T cells or evoked from neighboring cells can promote further recruitment of 
immune effectors (Islam and Luster, 2012; Sadik and Luster, 2012). Although these various 
cells and mediators are crucial to host defense, many of the molecules involved can cause 
substantial damage to host tissue. Thus, the quality, magnitude, and duration of effector T 
cell activity in a tissue site must be carefully regulated to provide a useful balance between 
adequate host protection and acceptable collateral organ damage (Germain et al., 2012; 
Sancho et al., 2002; Segel and Bar-Or, 1999).
Until recently, analysis of T cell effector activity, especially in peripheral tissues, was 
mainly indirect. Studies of gene-targeted animals have helped identify specific cytokines 
involved in protection against certain pathogens and flow cytometry and ELISA-based 
methods have revealed the relationship between cell phenotype and the capacity to produce 
these effector molecules, most often after ex vivo restimulation (Hafalla et al., 2012; Wilson 
et al., 2009). A more limited number of studies have examined cytokine production by T 
cells without such restimulation (Reinhardt et al., 2003). Static in vivo imaging with staining 
for both cell phenotypic markers and cytokines has also contributed to our understanding of 
the location and magnitude of effector T cell activity in tissues (Egen et al., 2011).
While this prior work has provided important insights about effector T cells and their 
behavior in antigen-rich settings, it lacks an understanding of the spatiotemporal dynamics 
of this limb of the immune system, in particular, the time evolution of the relationships 
among antigen recognition, cytokine production, and cell movement. The application of 2-
photon (2P) microscopy to intravital imaging of immune cells has provided a key tool for 
such analysis. Initially applied to the behavior of naïve T cells in secondary lymphoid tissues 
(Bousso and Robey, 2003; Mempel et al., 2004; Miller et al., 2002; Stoll et al., 2002), this 
method has more recently been used to analyze effector T cells in various peripheral sites 
(Bartholomaus et al., 2009; Beattie et al., 2010; Egen et al., 2011; Egen et al., 2008; Fife et 
al., 2009; Filipe-Santos et al., 2009; Kawakami et al., 2005; Kim et al., 2009; Matheu et al., 
2008; Schaeffer et al., 2009; Wilson et al., 2009). A common observation is the rapid 
movement of activated T cells within dense tissue and their migration arrest when contacting 
cells presenting antigen of suitable quality and quantity. In our studies involving a BCG-
induced liver granuloma model (Egen et al., 2011; Egen et al., 2008), we reported the close 
relationship between motility state and effector function, with the fraction of antigen-
specific cells showing antigen-induced arrest of migration correlating with the fraction 
producing interferon-gamma (IFN-γ). However, these and other investigations have not 
adequately explored the evolution of the effector response over longer time intervals for two 
major reasons; first, the lack of a method for narrowly defining the moment of initial antigen 
contact in the tissue so that the kinetics of the cytokine response can be linked to the onset of 
antigen-induced signaling, and second, the inability to image long enough to observe the 
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temporal arc of the functional response induced by such antigen stimulation. Without this 
information, critical questions about effector cell behavior such as what fraction of antigen-
specific cells participate in a response, whether actively migrating cells are high-rate 
cytokine producers, and the mechanisms controlling eventual T cell disengagement from 
antigen-specific contacts with APCs all remain unanswered.
To address these issues, we have combined 2P intravital microscopy with more traditional 
cellular analytical methods to examine the spatiotemporal behavior of CD4+ effector T cells 
in a skin delayed-type hypersensitivity (DTH) model. Two key elements of the study were 
the use of a method that synchronizes the onset of antigen presentation to T cells within an 
inflamed tissue site and the extension of the imaging analysis to a period of up to 10 hrs. 
Using these methods, we found that effector T cells exhibited reduced velocity and high 
IFN-γ production immediately after TCR engagement but gradually recovered motility and 
ceased effector activity over several hours through a process that was independent of marked 
decline in antigen presentation at the inflamed site. During this period, programmed death-1 
(PD-1) expression on effector T cells increased and blockade of PD-1 activity using an anti-
programmed death-ligand 1 (PD-L1) antibody delayed the recovery of motility and 
prolonged the duration of cytokine secretion. These results indicate that effector T cells 
undergo rapid tuning of their sensitivity to antigenic stimulation, in part through T cell 
receptor (TCR)-dependent negative feedback control afforded by increased PD-1 expression 
on T cells. We propose that this mechanism constrains tissue damage by adapting the 
magnitude of the effector response to the ambient amounts of antigen present within the 
inflamed site. These findings suggest a critical role for central memory cells in generating a 
continuous source of new ‘virgin’ effectors, which, upon sequential immigration into the 
inflamed site, can sense dynamic fluctuations in antigen display and generate a proportional 
effector response.
Results
Both antigen-induced signaling and tissue anatomy regulate motility of effector T cells in 
skin
To explore the dynamic behavior and functionality of effector T cells in a peripheral 
inflamed tissue in which we could control the display of cognate antigen and conduct long-
term dynamic in situ imaging, we developed a DTH model in which an adoptively 
transferred antigen-specific population of CD4+ T cells could be observed in the skin (Fig. 
1A) (Kearney et al., 1994). Naïve TCR transgenic OT-II-Rag-eGFP T cells (OT-II T cells) 
were transferred into syngeneic, albino recipient mice, to avoid tissue damage due to 
absorption of laser excitation by melanin granules (Masters et al., 2004). These animals 
were then immunized with complete Freund’s adjuvant (CFA) containing keyhole limpet 
hemocyanin (KLH) and the OT-II TCR-specific peptide ovalbumin 323-329 (OVA323). 
Seven days later, the ear skin was challenged with an intradermal injection of either KLH or 
KLH plus ovalbumin protein (OVA). Immunization and challenge with KLH evoked a DTH 
response that led to robust ear swelling 24-48 hrs later. Mice with primed OT-II T cells that 
were re-challenged with KLH+OVA developed only a marginally increased ear swelling 
response as compared to those re-challenged with KLH alone, suggesting that the majority 
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of inflammation is driven by the response to KLH (Figure. S1). The number of effector OT-
II T cells recruited into the inflamed ear at 12 and 60 hrs after the challenge was not 
substantially influenced by presence of specific antigen at these assay times (Fig. 1B,C), 
revealing that activated effector T cells were recruited to and retained in inflammatory skin 
lesions with limited dependence on their antigen specificity, consistent with our previous 
report (Egen et al., 2011). This homing characteristic allowed us to compare the behavior of 
effector OT-II T cells in KLH-challenged skin vs. KLH+OVA-challenged skin in the same 
animal and state of immune response, with the only major variable being the local presence 
or absence of specific antigen.
Using this system, we first characterized the localization and migration of OT-II T cells in 
inflamed skin in the absence of cognate antigen. Immunofluorescence analysis of skin 
sections showed a large number of recruited OT-II T cells in the dermis surrounded by a rich 
network of major histocompatibility complex (MHC) class II+ cells, representing potential 
APCs (Fig. 1D). In these fixed tissue sections we also observed smaller numbers of OT-II T 
cells in an epidermal compartment. We utilized intravital imaging to investigate the dynamic 
behavior of the dermal and epidermal OT-II T cell populations, performing the study in 
recipient mice that constitutively express dsRed in all cell types (Ubi-dsRed) so as to 
visualize the surrounding cellular environment. These studies revealed that the effector T 
cells were relatively free to move throughout the inflamed dermal environment with its 
looser mass of connective tissue and cells, whereas epidermal T cells appeared highly 
constrained by their surroundings, showing substantial shape changes as they squeezed 
through small openings between tightly adherent keratinocytes (Fig. 1E and Movie S1,S2). 
As a consequence, the mean velocity of T cells in the epidermis was substantially reduced 
compared to T cells migrating in the dermis (Fig. 1F), consistent with previously reports 
(Ariotti et al., 2012; Chodaczek et al., 2012; Gebhardt et al., 2011). These findings 
emphasize the critical importance of imaging tissue structure along with immune cells of 
interest in interpreting data on migration dynamics control, and provide insight relevant to 
effector cell clearance of epidermal infections. Given the limited motility of OT-II T cells in 
the epidermis and our interest in relating migratory dynamics to effector function, we 
focused on examination of dermal T cell populations for the remainder of our study.
We next investigated the effect of specific antigen on OT-II T cell migration in the inflamed 
dermis. Previous studies have demonstrated that effector T cells arrest migration when they 
contact a high potency antigen available at adequate density on tissue APC (Bartholomaus et 
al., 2009; Beattie et al., 2010; Egen et al., 2011; Fife et al., 2009; Filipe-Santos et al., 2009; 
Kawakami et al., 2005; Kim et al., 2009; Matheu et al., 2008; Schaeffer et al., 2009; Wilson 
et al., 2009). In agreement with these previous results and the abundance of potential APC in 
the dermis, at 12 hrs and 24 hrs after challenge with KLH+OVA, OT-II T cells in the dermis 
had a substantially lower mean velocity than OT-II T cells in the ear given only KLH (Fig. 
1G and Movie S3). In the absence of cognate antigen recognition (KLH challenge only), we 
observed a change in OT-II cell velocity as the DTH response progressed. Cell velocity 
increased slightly from 12 to 24 hours after KLH challenge but then decreased at later time 
points, presumably due to the changing inflammatory environment. By 48 hrs after the 
challenge, OT-II T cells in KLH+OVA challenged ears had regained motility close to that of 
OT-II T cells in the KLH challenged ear.
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Temporal synchronization of antigen presentation reveals that effector T cell motility and 
cytokine production are anti-correlated
Our observations demonstrating that at an inflamed site in the presence of antigen, effector 
OT-II T cell arrest their migration early in the response but then display heterogeneity in 
their motility as the response ensues, led us to investigate the process by which T cells 
engage with APCs, generate effector responses, and then disengage from APC contact, 
resuming migration. To generate a synchronized population of effector T cells in which the 
moment of antigen recognition is known within a narrow window, co-ordinate throughout 
the population, and observable during the imaging session, we developed a modified DTH 
system (Fig. 2A). Mice were immunized with KLH+OVA323 in CFA after transfer of naïve 
OT-II T cells and then challenged in the ear with KLH alone 7 days later to recruit OT-II 
effector T cells in the absence of cognate antigen. To synchronously induce and monitor 
activation of these T cells, OVA323 peptide was injected i,v, and OT-II T cell motility 
changes observed by intravital microscopy (Egen et al., 2011; Waite et al., 2011). Before 
antigen injection or following injection of an irrelevant peptide antigen, OT-II T cells moved 
rapidly with a mean velocity of ~5μm/min (Fig. 2B). Within 1 minute of OVA323 injection, 
antigen-specific T cells showed migration arrest, with higher doses of injected peptide 
leading to greater declines in the mean velocity (Fig. 2B and Movie S4), due primarily to 
more T cells arresting completely as the antigen dose increased (Figure. S2). To determine 
how these motility changes correlated with T cell effector activity, we examined the 
appearance of intracellular cytokine (IFN-γ) beginning at 2 hrs after peptide administration, 
using a previously described system in which T cells are analyzed directly ex vivo, in the 
absence of re-stimulation (Egen et al., 2011). The fraction of OT-II T cells producing IFN-γ 
increased in parallel with the change in the fraction of arrested cells (Fig. 2C, D), in accord 
with our previous findings (Egen et al., 2011).
Over the course of these acute peptide administration studies we found that the antigen-
arrested T cells began to regain motility several hours later (Fig. 2B). To extend these 
findings, we studied effector OT-II T cell dynamics in the skin of animals given 100μg of 
OVA323 peptide and subjected to 10 hrs of continuous imaging. These analyses confirmed 
that antigen-induced migration arrest was transient, with cells beginning to regain motility 
1-2 hrs after peptide injection and nearing their original speeds by 6-8 hrs (Fig. 2E and 
Movie S4). We also examined the migration of individual T cells (Figure. S3). Individual T 
cells rapidly arrested following peptide administration, but the subsequent recovery period 
was heterogeneous, with some cells regaining motility within 30 minutes and others 
remaining arrested for several hours. A rare population of T cells never regained motility 
during the imaging period. Following an extended arrest period induced by peptide 
injection, most T cells showed a prolonged recovery, oscillating between periods of brief 
arrest and motility, suggestive of additional TCR stimulation, before regaining a migration 
pattern similar to what was observed in the absence of antigen.
Ex vivo analysis of IFN-γ production without re-stimulation under the same experimental 
conditions showed an inverse relationship between migration and effector activity; T cells 
reached a peak of IFN-γ production by 2 hrs after initial antigen contact during which time 
they showed migration arrest; they then ceased making cytokine as they regained motility 
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over the next several hours (Fig. 2E). Given that the velocity change largely reflected 
individual cells transiting between the arrested and motile states (Figure. S3), these data are 
consistent with T cells making cytokine during prolonged contacts with APC and ending 
cytokine production as they transition back to the migratory state.
Intact antigen presentation after the regain of T cell motility
This ‘single cycle’ response of effector T cells in an inflamed tissue was unexpected and led 
us to investigate the molecular mechanisms underlying this behavior. Two major 
possibilities were considered; first, the loss of displayed pMHC ligands and the associated 
TCR ‘stop signal’ (Dustin, 2004) and second, a change in the response of the T cells to 
continued antigen display. We examined the first possibility by using a new cohort of 
adoptively transferred OT-II effector cells as a sensitive indicator of residual dermal antigen 
display when the in situ cohort of OT-II cells had regained motility several hours after 
antigenic stimulation. If we observed migration arrest of this new OT-II cohort but not of 
control effector T cells of a different specificity, this would exclude loss of antigenic signal 
as the basis of the termination of cytokine production and regain of migratory behavior. A 
DTH response to KLH was induced as before and the mice injected with OVA323 peptide to 
induce synchronized TCR activation. Nine hours after peptide injection, when the initial 
cohort of endogenously primed OT-II cells had regained motility, in vitro generated OT-II 
effector T cells and control p25 effector T cells recognizing the mycobacterial antigen, 
antigen-85b (Ag85b), were labeled with different dyes and adoptively transferred into the 
OVA323-challenged or saline-treated animals (Fig. 3A). In the OVA peptide-injected 
recipients, the in situ primed OT-II effector T cells had almost fully regained motility and 
moved at nearly the same velocity as the control transferred p25 T cells (Fig. 3B,C). In clear 
contrast, a large fraction of the newly transferred OT-II effector T cells showed markedly 
reduced velocity as compared to activated OT-II and p25 cells transferred into animals 
without OVA323 peptide injection, the migration-inhibited OT-II T cells that had recovered 
motility at this time point in peptide–treated animals, or p25 control cells in the same tissue 
(Fig. 3B-D, and Movie S5). These results indicated that dermal APCs still presented enough 
antigen to mediate specific migration arrest even 12 hrs after peptide administration, raising 
the possibility that dissociation of previously activated effector T cells from APCs and 
cessation of cytokine production beginning a few hours after initiation of peptide-dependent 
antigen presentation was linked to changes in the T cell response to an otherwise activating 
level of presented antigen.
PD-1 expression on T cells is increased after antigen-induced arrest
Multiple T cell-intrinsic processes could regulate the termination of TCR signaling and 
subsequent disengagement from APCs. The most direct mechanisms would involve antigen-
induced down-modulation of the TCR (Utzny et al., 2006; Valitutti et al., 2010), the CD4 
co-receptor (Schreiber et al., 2010) or other receptors mediating cell adhesion or regulating 
chemokine sensitivity. Alternatively, several T cell surface molecules have been proposed to 
actively inhibit antigen-induced stopping and promote T cell motility, including CTLA4 
(Downey et al., 2008; Schneider et al., 2006; Schneider et al., 2008), and PD-1 (Fife et al., 
2009; Schreiber et al., 2010). The surface expression of both CTLA4 and PD-1 is increased 
upon TCR signaling, so both were candidates for molecules that might contribute to time-
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dependent desensitization and loss of TCR-induced migration arrest and cytokine 
production. We therefore looked for changes in expression of various surface molecules on 
OT-II T cells after antigen-induced arrest (Fig. 4A). PD-1 but not CTLA4, Lag3 (another 
putative negative regulatory molecule), TCR, CD28, the integrins LFA-1,and ICAM, or 
various chemokine receptors showed substantial expression change within 3 hrs after 
antigen-induced arrest. For PD-1, there was a significant membrane increase in close kinetic 
correlation with the loss of migration arrest and effector activity (Fig. 4B). Given that the 
PD-1 ligands PD-L1 and PD-L2 are well expressed on skin CD11c+ MHCII+ cells (Figure. 
S4) and that these cells can serve as APCs for effector T cells during DTH responses (Movie 
S6), these results suggested the possibility that engagement of an increasing pool of surface 
PD-1 might play a role in the disengagement of T cells from APC and the regain of motility 
that begins a few hours after antigen activation in the skin.
Blockade of PD-L1 slows T cells motility recovery and prolongs cytokine production after 
antigen-induced arrest
To examine whether PD-1 played a role in regulation of T cell effector behavior after acute 
antigen activation, we inhibited its interaction with its ligands PD-L1 or PD-L2. Data were 
recorded in each experimental animal from a single imaging field before and then every 
hour after acute challenge with OVA323 for up to 8 hrs, allowing examination of the effects 
of antibody blockade on motility while taking into account animal to animal variability and 
effects of local differences in tissue structure and phase of the DTH response. In control 
mice given isotype-matched antibody, the average velocity of the OT-II T cells had 
recovered to the basal state by 6 hrs after antigen-induced arrest (Fig. 5A). In contrast, anti-
PD-L1 antibody treatment prolonged the duration of antigen-induced T cell arrest, with the 
average mean velocity remaining below baseline for the 6 hrs duration of the imaging 
session (Fig. 5B). There was no effect of anti-PD-L1 antibody on the velocity of effector T 
cells in the absence of antigen-specific engagement (data not shown). Administration of 
anti-PD-L2 antibody (Fig. 5C) or anti-CTLA4 antibody (Fig. 5D) did not result in the same 
change in motility re-acquisition by the T cells (summarized in Fig. 5E). While a trend 
towards slower recovery of motility was observed with anti-CTLA4 treatment, careful 
analysis of the area under the curve for the results shown in Fig. 5E revealed that only anti-
PD-L1 treatment had a significant effect on changes in motility following antigen-induced 
arrest (Fig. 5F). To control for T cell extrinsic effects of anti-PD-L1 treatment, we 
performed additional experiments using control effector p25 T cells. Mice were transferred 
with both OT-II-CFP T cells and p25-eGFP T cells, and then immunized with CFA 
containing OVA323 and Ag85b peptides to generate both types of effector T cells in situ. 
After KLH challenge, both effector populations were observed in the dermis and could be 
discriminated based on their unique fluorescent protein expression. Mice were treated with 
either anti-PD-L1 antibody or control isotype antibody, and then injected with OVA323. 
Antibody treatment did not affect initial antigen-induced arrest (Figure S5). At 8 hrs after 
OVA323 injection in animals given control antibody, the average velocity of OT-II-CFP T 
cells was the same as p25-eGFP-T cells, while in mice treated with anti-PD-L1 antibody, the 
average velocity of OT-II-CFP T cells was significantly lower than that of the p25-eGFP T 
cells (Fig. 5G,H and Movies S6), confirming that blockade of PD-L1 signaling caused a 
delay of T cell motility recovery in antigen-responding T cell populations, without affecting 
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the velocity of bystander populations of effector T cells that were not engaged with APCs. 
We also examined the effect of anti-PD-L1 treatment on T cell dynamics at 48 hours post-
rechallenge with OVA protein. Consistent with our findings using systemic peptide 
injection, we observed decreased T cell motility and displacement following PD-L1 
blockade (Figure S6).
Together, these data suggest that PD-L1 signaling through PD-1 on T cells can actively 
suppress antigen-driven T cell arrest. Given our previous observations on the anti-
correlation of effector T cell motility and cytokine production, we hypothesized that PD-1 
engagement with PD-L1 would also affect the temporal pattern of T cell effector function 
elicited by antigen stimulation. IFN-γ production from OT-II T cells after activation by 
OVA323 peptide injection was examined with or without anti-PD-L1 antibody 
administration. At 3 hrs after OVA323 injection, close to the normal peak of the cytokine 
response, there was no significant difference in the percentage of IFN-γ-producing OT-II T 
cells between isotype control treated mice and anti-PD-L1 antibody treated mice (Fig. 6B). 
However, 8 hrs after OVA323 injection when the cells had usually regained full motility and 
largely ceased induced cytokine production, the percentage of IFN-γ-producing cells was 
significantly higher in anti-PD-L1 antibody treated mice than in control mice (Fig. 6A,C), in 
accord with the accompanying delay in return to the motile state (Fig. 5B). Thus, PD-1 
ligation plays an important role in regulating the temporal evolution of both post-activation 
T cell migration dynamics and effector activity.
Discussion
Useful adaptive immune T cell responses in tissues involve the emigration of activated 
lymphocytes from the vasculature across inflamed endothelium into the tissue space. There 
these effector T cells migrate in search of cells displaying processed antigen in the context 
of MHCI or MHCII molecules which, when found, allow T cells to engage in host defense 
through activation of specific effector programs. The ensuing response must be robust 
enough to clear an invading pathogen but sufficiently restrained so as to prevent excessive 
tissue damage. To explore how effector T cell activity is controlled dynamically at sites of 
inflammation, we established a DTH model in which very tight temporal control of initial 
antigen recognition can be used to investigate the temporal connections between T cell 
migration, interaction with APC, and effector activity.
Consistent with our prior observations (Egen et al., 2011), we found that T cells rapidly 
arrest migration in response to antigen challenge, an event tightly linked to effector cytokine 
production. However, by 2-3 hrs after initiation of TCR signaling, effector cells exited their 
arrested state and began to migrate in the tissue while ceasing cytokine production. This 
‘single cycle’ response behavior occurred even though pMHC ligand density in the tissue 
was sufficient to cause antigen-specific T cell stopping. Analysis of negative regulatory 
pathways linked to TCR signaling revealed a major, though not exclusive role, for PD-1 
interaction with APC-expressed PD-L1 in actively terminating antigen-induced T cell arrest 
on APC and limiting the duration of cytokine production.
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The effect of antigen recognition on T cell motility has been previously examined in vitro 
and in vivo using various imaging modalities. In vitro, TCR engagement by strong agonist 
pMHC ligands at high densities induces a stop signal, with the T cell in tight synaptic 
connection with the APC membrane (Dustin, 2004; Negulescu et al., 1996). Intravital 
dynamic imaging first done in a rat experimental allergic encephalomyelitis model has 
shown that 40 % of transferred myelin basic protein -specific effector T cells become 
immobile within the central nervous system where their specific antigen exists, whereas 
almost all cells with an irrelevant TCR migrated vigorously unless their antigen was 
administered systemically (Kawakami et al., 2005). In several other models, the majority of 
specific but not unspecific CD4+ or CD8+ effector T cells in tissues or secondary lymphoid 
organs also stopped migrating in the presence of high amounts of cognate antigen (Azar et 
al., 2010; Filipe-Santos et al., 2009; Waite et al., 2011), and a similar pattern of TCR-
induced migration arrest on strong ligands is seen among thymocytes (Bhakta et al., 2005). 
In a more limited number of imaging studies, the presence of cognate antigen does not result 
in a statistically significant change in mean velocity of the antigen-specific population 
(Filipe-Santos et al., 2009; Kim et al., 2009; Schaeffer et al., 2009), although biological 
responses of these cells could be measured. This led to the interpretation that transient 
contact between the T cell and APC is adequate to drive full activation. However, our study 
in a BCG liver granuloma model has shown clearly that there is a close match in frequency 
between fully arrested T cells and cytokine-producing T cell in the lesion and that such cells 
represent only 5-10% of the population (Egen et al., 2011). Linkage of migration arrest and 
function could be missed in analyses reporting ‘multi-hit’ activation of continuously 
migrating T cells when looking only at mean velocity metrics under conditions in which 
only a small fraction of effectors at any moment were engaged in stopping behavior and 
response.
This issue of whether T cells respond only when arrested on APC or while still migrating is 
of critical importance in developing an understanding of the range over which cytokines 
might mediate their effects in vivo. Although diffusion or bulk flow in tissue fluid can in 
principle spread the signal from a cytokine secreted by an activated, arrested effector cell 
(Muller et al., 2012), migrating cells would clearly have an advantage in distributing such 
mediators widely in the tissue. This could either be of benefit in limiting infectious spread or 
detrimental by producing tissue damage at sites distant from foci of infection that require 
control. The data in the present report are consistent with our findings in the granuloma 
model (Egen et al., 2011), indicating that effector cells interacting with strong foreign 
antigens undergo activation while tightly associated with APC and rapidly cease cytokine 
production and secretion once TCR signaling wanes and contact is lost as migration 
resumes. Such findings point to a model of host defense in which locally secreted rather than 
widely distributed cytokines play a predominant role. This does not mean that the effect of a 
secreted cytokine is limited to just the APC conjugated with the arrested and activated T 
cells. IFN-γ effects can be measured 80-100 μm from an arrested and activated effector T 
cell (Muller et al., 2012). This makes biological sense, as the cells in the immediate vicinity 
of the APC are the most likely to become infected if microbe control is incomplete and 
hence, raising their resistance to productive infection is a useful host defense strategy.
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The upregulation of negative feedback regulators of TCR signaling, especially PD-1, 
appeared to play the major role in causing strongly arrested and activated T cells to regain 
motility and cease cytokine production within a few hours of initial antigen contact. Our 
findings are consistent with previous imaging studies showing that PD-1 interaction with its 
ligands on APC can limit the capacity of antigen to induce T cell migration arrest and 
response (Fife et al., 2009) and are further supported by the recent demonstration that PD-1 
interactions can inhibit proximal TCR signaling and thus limit the TCR-induced stop signal 
(Yokosuka et al., 2012). These data stand in contrast to a recent report that PD-1 promotes 
migration arrest and effector function of splenic CD8+ T cells in a viral infection model 
(Zinselmeyer et al., 2013); the basis for this difference in findings remains to be determined. 
We also observed a trend towards a modest decrease in the rate at which T cells regain 
motility following antigen engagement after blockade of CTLA-4, although these findings 
were not statistically significant. Nevertheless, a role for CTLA4 in reversing antigen-
induced migration arrest of T cells has been described in other circumstances (Downey et 
al., 2008; Schneider et al., 2006; Schneider et al., 2008) and given its endosomal localization 
and TCR signaling-induced stabilization on the cell surface (Egen and Allison, 2002; 
Linsley et al., 1996), it is tempting to speculate that CTLA-4 may also function to sense the 
extent of antigen engagement and modulate the duration of T cell contacts with APCs.
At first glance, it seems counter-intuitive that activated effector T cells would cut short their 
response to antigen while the latter persists in amounts adequate for effective stimulation of 
newly arriving T cells of the same specificity. However, there are several reasons why 
adaptively decreasing T cell antigen sensitivity could be beneficial to immune responses. 
Regulatory programs that actively promote disengagement of T cells from APCs may 
prevent T cells from being trapped around inflamed venules on the first antigen-bearing 
APC they encounter and thereby promote both the migration of T cells deeper into inflamed 
tissue. In addition, general considerations of homeostasis as well as explicit modeling have 
both suggested that the immune system must find a careful balance between effective host 
defense and the disruption of tissue integrity due to the toxic effects of mediators such as 
cytokines, enzymes, and reactive oxygen species (Grossman and Paul, 1992; Segel and Bar-
Or, 1999). Regulatory mechanisms that rapidly tune down T cell antigen sensitivity to a 
point that precludes prolonged responses to the antigen density that first evoked the response 
may provide one solution to this problem. Of course, local desensitization of T cell 
activation thresholds could also give pathogens a respite from attack if mechanisms do not 
exist to maintain the T response in the face of continuing infection. We propose that rapid 
antigen-driven desensitization of T cells at the site of infection combined with a continuous 
influx of newly generated effector T cells capable of delivering a transient burst of activity, 
allows for rapidly tuning the potency of T cell responses in co-ordination with fluctuations 
in antigen display. If antigen presentation is increasing, T cells at the site of infection will be 
able to respond even with the sensitivity loss that has occurred. If the antigen amount is 
stable or falling, however, T cells already at the site of infection will cease to participate in 
the response and continued effector activity will be dependent on newly arriving effector T 
cells coming from stem cell-like central memory cells (Gattinoni et al., 2011) and capable of 
being activated by this lower amount of antigen. These cells, produced within draining 
lymphoid organs, will only be activated upon arrival in the infected tissue to the extent they 
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are required to drive down pathogen load and no more due to the same desensitization 
mechanism, thus maximizing tissue viability while effectively defending the host. Seen in 
this framework, the feedback-controlled, time-limited activity of effector T cells we 
document here provides insights into how the immune system balances the competing 
requirements of host defense and tissue homeostasis.
Methods
Mice
C57BL/6 OT-II TCR transgenic RAG1-deficient mice (Barnden et al., 1998) and CD11c-
YFP (Lindquist et al., 2004) mice were from Taconic Laboratories. C57BL/6 p25 TCR 
transgenic RAG1-deficient animals were kindly provided by J. Ernst (New York University 
School of Medicine, New York) (Wolf et al., 2008). Albino C57BL/6-Tyrc-2J/c-2J mice, 
C57BL/6 ubiquitously expressing eGFP or dsRed (Schaefer et al., 2001; Vintersten et al., 
2004), were from Jackson Laboratories. All mice were maintained in specific-pathogen-free 
conditions at an Association for Assessment and Accreditation of Laboratory Animal Care-
accredited animal facility at the NIAID. All procedures were approved by the NIAID 
Animal Care and Use Committee (National Institutes of Health, Bethesda, MD).
DTH
Recipient mice were transferred with 2 × 104 T cells from donor mice by i.v. injection. The 
recipient mice were then immunized with 100μl of emulsion of complete Freund’s adjuvant 
plus 50μg KLH and 25μg ovalbumin 323-339 peptide (OT-II) or Ag85b 240-254 peptide 
(p25) at the base of the tail the next day. 7 days later after the immunization, ear skin was 
challenged i.d. with 20μg KLH and/or OVA. Intravital imaging or flow cytometry analysis 
was performed 48-72 hrs after the challenge.
Blocking antibodies
Rat IgG, anti-PD-L1 (10F.9G2), anti-CTLA4 (UC10-4F10-11) (all from BioXCell), and 
anti-PD-L2 (3.2) (kindly provided by Gordon J Freeman, Dana-Farber Cancer Institute, 
Boston, MA), were injected intravenously at 300 μg/mouse one day and one hour before 
OVA peptide injection.
In vitro T cell stimulation and adoptive transfer
For in vitro generated effector T cells, lymph nodes from TCR transgenic mice were 
disrupted by passage through a 70μm cell strainer (BD Biosciences). 1 × 106 cells were 
stimulated with 1 × 107 mitomycin C-treated C57BL/6 splenocytes in complete RPMI 1640 
(10% FCS, 2mM L-glutamine, 50mM 2-mercaptoethanol, and penicillin plus streptomycin) 
plus 2μM ovalbumin 323-339 peptide (OT-II) or Ag85b 240-254 peptide (p25) in each well 
of a 24-well plate. Two days after the stimulation, cells were expanded in the presence of 
20U/ml recombinant human IL-2 (R&D systems) and used for experiments 6–7 days post 
activation. In vitro generated effector T cells were labeled with 1μM CMTPX or 100μM cell 
tracker blue for 15 min at 37 C in HBSS or 10μM CMTMR (Invitrogen) for 15 min at 37°C 
in complete RPMI. 0.5-1 × 107 of each cell type was injected i.v. into recipient animals.
Honda et al. Page 11









Cell isolation and Flow Cytometry
For skin lymphocyte isolation, ear skin was cut and separated from the cartilage. The 
separated ears were put into RPMI+1% fetal calf serum containing 0.33mg/ml of Liberase 
TL (Roche), 0.05% DNase I (Boehringer Mannheim) for 1 hour at 37°C. After the 
incubation, the tissue was disrupted by passage through a 70μm cell strainer. Cell 
suspensions were washed and stained with respective antibodies. For analysis of 
intracellular cytokine production, cell suspensions were obtained in the same manner except 
that 10μg/ml of BFA (Sigma) was included in the digest buffer and subsequent steps were 
performed in the presence of 5μg/ml BFA. Cells were surface stained with anti-CD4 
eFluor450 (Clone RM4-5), anti-PD-1 PeCy7 (Clone 29F.1A12) (Biolegend), anti-Lag3 PE 
(Clone eBioC9B7W), anti-Vα2−TCR PE (Clone B20.1), anti-CD3 PeCy7 (Clone 
145-2C11), anti-ICAM-1 alexa700 (Clone YN1/1.7.4), anti-LFA-1 PE (Clone M17/4), anti-
CD28 PE (Clone 37.51), anti-PD-L1 APC (Clone 10F.9G2), anti-CXCR3 PE (Clone 
CXCR3-173), anti-CCR4 PeCy7 (Clone 2G12), anti-Vb11 biotin (Clone RR3-15). Cells 
were fixed with Cytofix buffer, permeabilized with Perm/Wash buffer (BD Biosciences), 
and stained with anti-IFN-γ Alexa Fluor 647 (Clone XMG1.2) or anti-CTLA4 (Clone 
UC10-4B9). eGFP was detected in the FITC channel and isotype controls were used to 
determine background signals for intracellular stains. Flow cytometric data were collected 
on an LSR II (BD Biosciences) and analyzed with FlowJo software (TreeStar).
Intravital Multiphoton Microscopy
Mice were anesthetized and prepared for intravital 2P imaging. Briefly, the mouse was 
anesthetized using isoflurane and placed on a custom-designed stage in a heat box. Ear skin 
was wet with a few drops of PBS and gently placed onto a coverslip and covered with a 
tape. For acute injection of peptide antigens during imaging, a catheter was placed into the 
tail vein via a 30GA needle attached to PE-10 tubing (Becton Dickinson) and secured with 
Durapore Tape (Fischer Scientific). Images were acquired on an LSM 510 NLO multiphoton 
imaging system (Carl Zeiss Microimaging) or LSM 710 NLO multiphoton imaging system 
(Carl Zeiss Microimaging), typically 10 z planes spaced 3μm apart every 45 seconds. 
Fluorescence excitation was provided by a Chameleon Ti:Sapphire laser (Coherent). eGFP 
and CFP were excited at 920nm or 900nm while CMFDA and CMTPX were excited at 
840nm. Raw imaging data were processed with Imaris (Biplane). Automatic object tracking 
via Imaris Spots was aided with manual corrections to retrieve cell spatial coordinates over 
time and the resulting data analyzed in MATLAB (MathWorks). AfterEffects (Adobe) or 
ImageJ software (National Institute of Health) was used to produce video clips.
Statistical analysis
Data were analyzed with GraphPad Prism5 software. P values were calculated by the 
unpaired Student’s t-test and values of 0.05 or less were considered significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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- Effector CD4+ T cell function and motility inversely correlate in inflamed tissue.
- Antigen sensitivity tuning limits the duration of effector T cell activity in vivo.
- PD-1 upregulation contributes to sensitivity loss and cessation of effector function.
- Feedback regulation of effector activity appears to balance peripheral host defense 
and tissue damage.
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Figure 1. Characterization of antigen-dependent and independent effector T cell behavior in 
inflamed skin
(A) Schematic illustration of DTH induction. (B) Representative histograms and (C) 
quantification of CD4+eGFP+ OT-II T cells from inflamed skin. Ear skin was collected at 
the indicated time point and cell composition was analyzed by flow cytometry after tissue 
disruption. Graph shows the percent of CD4+ cells that are eGFP+; mean +/− SD from at 
least three mice per group. (D) Immunofluorescence staining of an inflamed ear section 
containing OT-II eGFP+ cells during a DTH response. 48 hrs after KLH challenge, ear skin 
was fixed, sectioned, and stained with DAPI to identify nuclei and an anti-MHC-II Ab. 
Epidermis (Epi), dermis (Derm), and cartilage (Cart) regions of the ear are indicated. Note, 
the side of the ear receiving an intradermal injection of antigen shows the most 
inflammation and dermal swelling. (E) Representative picture of OT-II T cells in epidermis 
(upper panel) and dermis (lower panel). See also Movie S1. (F) Comparison of OT-II T cell 
mean velocity in dermis and epidermis. Each symbol represents an individual cell. 
Horizontal lines indicate median value of the population. (G) Quantification of mean 
velocity for dermal OT-II T cells in the presence and absence of cognate antigen. Each 
symbol represents an individual cell. Horizontal lines indicate median value of the 
population. P values, unpaired Student’s t-test. See also Movie S2. All data are 
representative of three or more independent experiments. Scale bars: 50μm
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Figure 2. Synchronized activation of effector T cells reveals inverse correlation between effector 
function and motility
(A) Schematic illustration of modified DTH system. (B) Antigen-induced OT-II T cell arrest 
in response to different doses of OVA323 peptide. Each line represents the average 
normalized instantaneous velocity over time from an individual animal treated at a given 
peptide dose. The velocity before OVA323 peptide administration is normalized to one. 
Data are compiled from multiple experiments. See also Movie S3. (C) Representative flow 
cytometry histograms and (D) quantification of IFN-γ production from OT-II T cells 2 hrs 
after administration of different doses of OVA323 peptide. Graph shows the percent OTII-T 
cells that are IFN-γ+; mean +/− SEM from at least 3 mice per group. (E) OT-II T cell 
instantaneous velocity over time and the percent OT-II T cells that are IFN-γ+ before and 
after administration of 100μg of OVA323. See also Movie S4. All data are representative of 
three or more independent experiments.
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Figure 3. Antigen presentation persists after the regain of T cell motility
(A) Schematic illustration of experimental protocol. (B) Representative image from an 
intravital data set (left panel). Image was taken 12 hrs after administration of 100μg of 
OVA323. In vitro primed OT-II T cells and p25 T cells were labeled with CMTMR (red) 
and Cell Tracker blue (blue), respectively, and transferred 3 hrs before image acquisition. 
Right panel shows the paths of T cell migration over the duration of the movie. See also 
Movie S5. (C and D) Quantification of mean velocity for endogenously primed OT-II T 
cells and in vitro generated OT-II T cells and p25 T cells. Horizontal lines indicate median 
value of the population. Data are representative of two independent experiments. Scale bars: 
50μm
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Figure 4. Expression of surface molecules on OT-II T cells after OVA323 administration
(A) Representative histogram of various surface molecules on OT-II T cells from at least 
three independent experiments. DTH ear skin was collected and digested at the indicated 
time point after administration of 100μg of OVA323 and cells were surface stained with the 
indicated antibodies. Intracellular staining was performed for CTLA4. (B) The median 
fluorescence intensity (MFI) of PD-1 staining was quantified before and after peptide 
administration. All values were normalized to the average MFI of the OVA(-) group, set as 
100. P values, unpaired Student’s t-test.
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Figure 5. Effect of blocking antibodies on the recovery of T cell motility after OVA323 
administration
(A-D) Representative time course of mean velocity for OT-II T cells before and after 
administration of 100μg of OVA323 in the presence of the indicated antibodies. The median 
value of the population before OVA323 administration was set as one, and each dot 
indicates an individual cell. Blue horizontal lines indicate the ratio of mean velocity to initial 
velocity at the indicated time point, and red dashed lines indicate initial velocity. Data are 
generated from 30 minute data sets beginning at each indicated time point. (E) Summary of 
the time course of T cell motility change from data in (A-D). Each symbol indicates the ratio 
of the mean velocity as in (A-D). (F) Quantification of motility recovery for OT-II T cells in 
the presence of different blocking antibodies. Area under the curve in (E) was measured. 
Each symbol indicates area under the curve for an individual independent experiment. (G, 
H) Comparison of mean velocity between in vivo primed p25 T cells and OT-II T cells 8 hrs 
after OVA 323 stimulation either with isotype antibody treatment (G) or anti-PD-L1 
antibody (H). See also Movies S6. Data are representative of three or more independent 
experiments. P values, unpaired Student’s t-test. n.s.- not significant.
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Figure 6. PD-L1 blockade prolongs effector function of OT-II T cells after antigen-induced 
arrest
(A) Representative contour plots and (B) quantification for IFN-γ production from OT-II T 
cells in the presence and absence of anti-PD-L1 antibody. DTH was induced in primed mice 
and the animals treated with isotype control or anti-PD-L1 blocking antibody prior to 
administration of 100μg OVA323. Skin cells were collected 3 hrs (B) or 8 hrs (A and C) 
after OVA323 administration and intracellular staining for IFN-γ was performed. Each 
symbol in (B and C) indicates the result from an individual mouse. Data are representative 
of three or more independent experiments. P values, unpaired Student’s t-test. n.s.- not 
significant.
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